- Do you need additional expertise in determining the approach to move your compound to the next stage?
- Do you need an out-of-the-box solution to address questions that standard models won't answer?
- Do you need a preclinical partner that can bring value to the table?
- Do you have a limited timeline for results?
- Do you experience a bottleneck waiting for in-house study slots to free up?
Whatever is driving the decision to outsource, MD Biosciences provides options that can help you push past the hurdle and get your compound moving forward. Read the case study to learn how other pharma and device companies have successfuly used MD Biosciences preclinical services to meet the following business objectives:
- Licencising/Aquisition
- Repositioning/Therapeutic Expansion
- Custom approaches for NCEs/biologics/devices